Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Moharram Ventures Inc. operates in the Biotechnology & Pharmaceuticals technology area. There is 1 pending office action currently active in the company's portfolio. This workload involves 1 distinct examiner and 1 distinct art unit. The prosecution is currently limited to this lone point of contact within the biotechnology field, indicating a specific area of intellectual property focus for the entity. The consolidation of the workload into a single unit suggests a highly targeted approach to securing intellectual property rights within the biotechnology sector.
RAMIREZ, DELIA M is the busiest examiner for Moharram Ventures Inc. This examiner is managing 1 busiest examiner pending office action. Since this examiner is responsible for all current prosecution matters, the portfolio allows for a specific approach focusing on the examiner's history and the art unit's standards. The lack of other pending actions means that the company's current patent office strategy is concentrated on the decisions made by this single examiner and their review of the active application. Practitioners can benefit from a detailed analysis of the examiner's historical actions, as this individual's perspective will be the primary influence on the portfolio's immediate future.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAMIREZ, DELIA M | 1 | 65.1% | +56.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17270690 | Method for Producing Biodegradable Polymer | RAMIREZ, DELIA M | 87d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17270690 | Method for Producing Biodegradable Polymer | RAMIREZ, DELIA M | 87d overdue |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17270690 | Method for Producing Biodegradable Polymer | RAMIREZ, DELIA M | 1652 | §103§112 | Final Rejection | 87d overdue | Pending | Feb 23, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMoharram Ventures Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Delia M Ramirez has the most, with 1 of Moharram Ventures Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.